| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
CD34 molecule | 0.368 | 0.808 | 5.0E-06 |
|
group | 0.100 | None | 0.991 | 114 | 0 | 1994 | 2020 | ||||||||
|
RUNX family transcription factor 1 | 0.425 | 0.808 | 0.65 |
|
group | 0.500 | None | 1.000 | 88 | 0 | 1993 | 2020 | ||||||||
|
FA complementation group B | 0.468 | 0.769 | 1.00 |
|
group | 0.500 | strong | 0.963 | 53 | 0 | 1984 | 2020 | ||||||||
|
colony stimulating factor 3 | 0.377 | 0.885 | 0.38 |
|
group | 0.100 | None | 0.977 | 42 | 0 | 1990 | 2020 | ||||||||
|
nucleoporin 98 and 96 precursor | 0.532 | 0.577 | 1.00 |
|
group | 0.100 | None | 1.000 | 37 | 0 | 1999 | 2019 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
group | 0.100 | None | 0.914 | 35 | 0 | 1996 | 2018 | ||||||||
|
cyclin dependent kinase inhibitor 2B | 0.417 | 0.769 | 7.3E-03 |
|
group | 0.400 | None | 0.970 | 32 | 0 | 1995 | 2019 | ||||||||
|
NRAS proto-oncogene, GTPase | 0.390 | 0.808 | 0.49 |
|
group | 0.200 | None | 1.000 | 29 | 0 | 1987 | 2019 | ||||||||
|
nucleophosmin 1 | 0.464 | 0.846 | 1.00 |
|
group | 0.100 | None | 0.966 | 29 | 0 | 1996 | 2019 | ||||||||
|
lysine methyltransferase 2A | 0.410 | 0.885 | 1.00 |
|
group | 0.100 | None | 0.931 | 28 | 0 | 1997 | 2019 | ||||||||
|
enhancer of zeste 2 polycomb repressive complex 2 subunit | 0.376 | 0.885 | 1.00 |
|
group | 0.400 | None | 0.962 | 26 | 0 | 2010 | 2019 | ||||||||
|
C-C motif chemokine receptor 7 | 0.443 | 0.769 | 5.8E-02 |
|
group | 0.100 | None | 1.000 | 26 | 0 | 1994 | 2018 | ||||||||
|
colony stimulating factor 2 | 0.330 | 0.962 | 0.83 |
|
group | 0.100 | None | 1.000 | 22 | 0 | 1989 | 2018 | ||||||||
|
WT1 transcription factor | 0.422 | 0.808 | 1.00 |
|
group | 0.100 | None | 1.000 | 19 | 0 | 1998 | 2019 | ||||||||
|
DNA methyltransferase 3 alpha | 0.445 | 0.846 | 7.4E-39 |
|
group | 0.200 | None | 0.947 | 18 | 0 | 2009 | 2019 | ||||||||
|
ETS variant transcription factor 6 | 0.477 | 0.731 | 0.97 |
|
group | 0.100 | None | 1.000 | 16 | 0 | 1995 | 2019 | ||||||||
|
glutathione S-transferase theta 1 | 0.393 | 0.923 | 1.5E-04 |
|
group | 0.100 | None | 0.867 | 15 | 0 | 1996 | 2013 | ||||||||
|
ribosomal protein S14 | 0.631 | 0.500 | 0.90 |
|
group | 0.200 | None | 1.000 | 14 | 0 | 2009 | 2019 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
group | 0.100 | None | 0.933 | 14 | 0 | 1995 | 2019 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
group | 0.100 | None | 0.923 | 13 | 0 | 1995 | 2019 | ||||||||
|
interferon regulatory factor 1 | 0.468 | 0.769 | 0.99 |
|
group | 0.100 | None | 1.000 | 13 | 0 | 1993 | 2017 | ||||||||
|
BCR activator of RhoGEF and GTPase | 0.431 | 0.885 | 0.99 |
|
group | 0.100 | None | 0.833 | 12 | 0 | 1991 | 2018 | ||||||||
|
CD274 molecule | 0.324 | 0.923 | 1.9E-02 |
|
group | 0.100 | None | 1.000 | 12 | 0 | 2010 | 2019 | ||||||||
|
ABL proto-oncogene 1, non-receptor tyrosine kinase | 0.432 | 0.923 | 1.00 |
|
group | 0.100 | None | 1.000 | 12 | 0 | 1996 | 2012 | ||||||||
|
CCAAT enhancer binding protein alpha | 0.496 | 0.692 | 0.55 |
|
group | 0.400 | None | 0.923 | 12 | 0 | 2002 | 2020 |